Skip to main content
Virulence logoLink to Virulence
. 2021 Mar 29;12(1):981–988. doi: 10.1080/21505594.2021.1903212

Altered expression of genes related to innate antifungal immunity in the absence of galectin-3

Caroline Patini Rezende a, Patricia Kellen Martins Oliveira Brito b, Andre Moreira Pessoni a, Thiago Aparecido Da Silva b, Gustavo H Goldman c, Fausto Almeida a,
PMCID: PMC8009118  PMID: 33779504

ABSTRACT

Galectin-3 (Gal-3) is the most studied member of the animal galectin family, which comprises β-galactoside-binding lectins and participates in several cellular events. Its expression in cells involved in innate and adaptive immunity is related to anti- and proinflammatory functions, signaling an important role in inflammatory, infectious, and tumorigenesis processes. Mice deficient in Gal-3 exhibit important phenotypes, but it is unclear whether these phenotypes reflect an impairment of the functions of this protein. Gal-3 plays an important role in modulating the immune response to different pathogenic microorganisms. However, the role of Gal-3 in immunity to infection is still poorly understood. Therefore, we investigated the effects of Gal-3 deletion on the expression of genes involved in the innate immune response in the lungs, spleens, and brains of Gal-3 KO mice. Gene profiling expression analysis suggested that Gal-3 deletion resulted in differentially modulated expression of the genes encoding beta-glucan, mannose and chitin-responsive pattern recognition receptors, signal transduction, inflammation, and phagocytosis. Our data thus suggest the importance of Gal-3 expression in the host innate immune system.

KEYWORDS: Galectin-3, gene knockout, innate immune response, antifungal immunity, gene expression

Introduction

Galectins are a family of animal β-galactoside-binding lectins [1,2]. This family consists of 15 multifunctional members [3], which are expressed in the nucleus, cytoplasm or cell membranes, or secreted extracellularly [1]. Galectins can bind glycoconjugates on the cell surface, triggering a transmembrane signaling cascade [3–5], which modulates several biological processes such as apoptosis, immune cell activation, cell adhesion, and cytokine secretion [6].

Galectin-3 (Gal-3) is the most studied member of the galectin family. The protein is expressed in various types of immune cells, tissues, and organs at different stages of development [7,8]. Its expression depends on the stage of the cell cycle and the metabolic status of the cell [9,10], while its biological functions are defined by its intracellular selectivity or extracellular localization [11]. Gal-3 can associate with the cell surface or localize in the extracellular matrix [12,13]. Extracellularly, Gal-3 exerts several autocrine and paracrine effects, which can mediate cell adhesion and activation by acting as chemoattractants for certain types of cells [3].

The expression of Gal-3 in cells of the innate and adaptive immune systems is related to anti- and proinflammatory functions [14–17], signaling important roles in inflammatory and infectious processes [16]. Depending on their ligands, Gal-3 has varied functions and participates in several cellular events [16]. Therefore, Gal-3 pathophysiological activities are associated with autoimmune diseases, tumorigenesis, and fungal or parasitic infections [18].

Notably, mice deficient in Gal-3 exhibit several important phenotypes such as impaired development [19], inflammatory functions [20] and stress control increased compulsive behavior [21] and high susceptibility to fungal infections [22–25]. Although it is unclear whether these phenotypes reflect an impairment of the intra- or extracellular functions of this protein [26]. In the population, the existence of single nucleotide polymorphisms (SNPs) in the gene encoding Gal-3 (lgals3) promotes variations in their serum levels in children with respiratory tract infections [27] and in diseases such as rheumatoid arthritis [28], malignant tumors [29], cardiomyopathies [30], but there is nothing related to fungal infections. Studies show that SNPs in the ptx3 [31] and clec7a [32] are associated with an increased risk of developing aspergillosis and candidiasis. Also, the presence of SNPs in host immunity genes, especially in standard recognition receptors (PRRs) such as toll-like receptors [33], C-type lectin receptors [34,35], pentraxins [36] and tumor necrosis factor receptors [37,38], may contribute to agreater susceptibility to fungal infections [39].

Therefore, we investigated whether Gal-3 deficiency promoted changes in the expression of innate immune response in the lungs, spleens and brains of Gal-3 KO mice compared to wild-type controls. Gene expression profiling analysis suggested that the absence of Gal-3 was associated with both enhanced and decreased expression of genes involved in the transcription of beta-glucan, mannose and chitin-responsive pattern recognition receptors (PRRs), signal transduction, inflammation, and phagocytosis. Our data suggest the importance of Gal-3 expression during innate immune responses.

Materials and methods

Animals

Six-to-eight-week-old, male C57BL/6 (wild type, WT) and Gal-3 Knockout (Gal-3 KO) mice were obtained from the animal housing facility at the Ribeirao Preto campus at the University of São Paulo (Ribeirao Preto, São Paulo, Brazil). Gal-3 KO mice were generated in the C57BL/6 mouse background as previously described and bred for nine generations [20]. The animals were housed in the animal facility at Ribeirao Preto Medical School at the University of São Paulo under optimized hygienic conditions. All animal experiments were conducted according to the Brazilian College of Animal Experimentation Protocol 100/2015 and approved by the Committee on Ethics in Animal Research at Ribeirao Preto Medical School at the University of São Paulo.

PCR array

WT and Gal-3 KO mice were euthanized and lung, spleen and brain fragments were aseptically harvested and homogenized in a tissue homogenizer (IKA® T10 basic homogenizer). Total RNA was extracted from the lung, spleen and brain homogenates using TRIzol reagent (Invitrogen Corporation, California, USA), according to the manufacturer’s instructions. The concentration of the eluted total RNA was assessed by absorbance ratios (A260/A280 and A260/A230) on a spectrophotometer (NanoDrop, Thermo Fisher Scientific, Wilmington, Delaware, USA). RNA integrity was evaluated by electrophoresis on a 1.8% agarose gel to check the presence of the 28S and 18S bands. cDNA was synthesized by reverse transcription with oligo d(T) primers using the ImProm-IITM Reverse Transcription System Kit (Promega Corp., Fitchburg, WI). The Mouse Antifungal Response RT2 Profiler PCR Array Kit (Qiagen Cat# PAMM-147Z) was used for gene expression analysis. This arrangement consisted of a plate containing 84 lyophilized primers targeting genes involved in the innate immune response to fungal infection (cited in Table S1), and negative controls for genomic DNA and primers targeting six different constituent genes. Pooled cDNA was mixed with buffer, DNA polymerase, SYBR Green Mastermix (2X RT2 SYBR Green Mastermix, SABiosciences-Qiagen), and water and partitioned among the 96 wells of the plate (25 μL per well). Real-time PCR was performed in a BioRad CFX 96 thermal cycler (C1000 TM thermal cycler) with the following cycling conditions: 95°C for 10 min; then, 40 cycles of 95°C for 15 sec and 60°C for 60 sec. Ct (threshold cycle) values were analyzed using SABiosciences Web software available online through the Qiagen Data Analysis Center website.

Statistical analysis

The Ct values were normalized using selected reference genes (gusb, hprt1, hsp90ab1, gadph and actb), which showed more stable expression between experimental and control groups. If more than one control gene was selected for normalization, the geometric mean of its values was performed. Our data were normalized with b2m, gapdh, gusb, and hsp90ab1 for the lungs; hsp90ab1 for the spleens, and actb, b2m, and gusb for the brains. The Ct values were geometrically calculated and used to determine 2−ΔΔCt. Differences in transcript levels (fold change (FC)) between experimental and control groups were determined using the Ct comparison method, based on the 2−ΔΔCt algorithm. Genes were considered significantly modulated (induced or repressed) if the difference in the mean 2−ΔΔCt values was greater than 2 or less than −2.

Results

Genes upregulated in Gal-3 KO mice compared to wild-type mice

The levels of expression of 84 genes present in the Mouse Antifungal Response RT2 Profiler PCR Array Kit were evaluated in Gal-3 KO mice relative to WT mice. This approach helped elucidate the role of Gal-3 in modulating genes expressed during the innate immune response (Figure 1 and Table S2). A total of 19 genes were upregulated in the lungs, spleens and brains of Gal-3 KO mice, with fold regulation greater than 2. Notably, only mannose-binding lectin 2 (mbl2), which is involved in the initial activation of the complement system, inflammation and phagocytosis, was overexpressed in the lungs (Table S3). In the spleen, genes encoding the chemokine (C-C-motif) receptor 5 (ccr5), mannose receptor C type 1 (mrc1), and toll-like receptor 9 (tlr9) were upregulated (Table S4). Sixteen genes were upregulated in the brain, including complement component 3 (c3), caspase 1 (casp1), chemokines (ccl5, ccl12, cxcl10), cd36, cd209a, C-type lectin domain family 4 and 7 (clec4n and clec7a), colony stimulating factor 2 (csf2), interleukins (il-1β, il-2, il-12b), mannose-binding lectin 2 (mbl2), pentraxin (ptx3), and surfactant-associated protein D(sfpd) (Table S5). These gene expression profiles demonstrated that absence of Gal-3 upregulates pro-inflammatory mediators and PRRs, with the notable highlight of mbl2 upregulation in the lungs and brain (Figure 2).

Figure 1.

Figure 1.

Heat map showing expression of genes in the innate immune response in the absence of Gal-3

Gene expression analyses in the lungs, spleens and brains of Gal-3 KO and WT mice (control) during the innate response. Ct (threshold cycle) values were transferred to SABiosciences Web software available online via the Qiagen website. Fold regulation cut off = 2 and pvalue cut off = 0,05. The scale represents fold change, with threshold set to 3 (green: upregulated, red: downregulated, black: medium change).

Figure 2.

Figure 2.

Up- and downregulation of innate immunity genes in Gal-3 KO mice

Comparative Venn diagram showing genes up- and downregulated in the lungs, spleens and brains of Gal-3 KO mice. Mbl2 and Ccr5 were up- and downregulated, respectively, in the lungs and brains. C3, Ccl20, Cxcl3, Il-1α, Il-12b, Myd88, and Syk were negatively modulated in spleens and lungs. Fos and Nptx1 were downregulated in spleens and brains. Venn diagram was designed using Venny 2.1.

Genes downregulated in Gal-3 KO mice compared to wild-type mice

The absence of Gal-3 in downregulating genes expressed in innate antifungal immunity in the lungs, spleens, and brains of Gal-3 KO mice was evaluated. Of the 84 genes tested, 42 genes were downregulated in the three types of tissues studied, with fold regulation less than −2 (Figure 1 and Table S2). In the lungs, 13 genes were downregulated in Gal-3 KO mice, including c3, ccl20, cxcl3, cxcl10, ccr5, csf2, fcgr1, il-1α, il-6, il-12a, il-12b, myd88, and syk. These genes encode components of the complement system, proinflammatory mediators, chemokines and its receptors, adaptor proteins and effectors of the PRR signal transduction pathway and phagocytosis (Table S3). In the spleens of Gal-3 KO mice, 35 genes were downregulated. These genes were categorized into PRRs (cd36, cd207, chia1, clec7a, nptx1, ptx3, scarf1); signal transduction (bcl10, card9, fos, irak4, ikbkb, itgb2, jun, malt1, map2k4, map3k7, mapk14, syk); inflammation (c3, ccl20, cxcll, cxcl3, cxcl11, f3, il-1α, il-1β, il-12b, il1r1, mbl2, myd88); gene responsive to pathogenic fungi (socs3); and phagocytosis (cd14, fcgr4, sftpd) (Table S4). Four genes (ccr5, colec12, fos and nptx1) were downregulated in Gal-3 KO mice brains. colec12 and nptx1 are involved in recognition; fos, in the signal transduction pathways of toll-like receptors; ccr5 and fos, in inflammation; and colec12, in phagocytosis (Table S5). Overall, most of the negatively regulated genes were found in the spleen, while fos and nptx1 were also downregulated in the brain. In addition, seven genes (c3, ccl20, cxcl3, il-1α, il-12b, myd88, syk), which were downregulated in Gal-3 KO mice spleens, were also downregulated in the lungs. Only the gene encoding chemokine (C-Cmotif) receptor 5 (ccr5) was downregulated in both lungs and brains (Figure 2).

Discussion

Gal-3 is involved in several biological processes such as angiogenesis, tumor invasion, metastasis, immune response, and maintenance of cellular homeostasis [3,13,40]. This protein is expressed in immune system cells including monocytes, macrophages, B and T lymphocytes, dendritic cells, eosinophils, and neutrophils [41,42], indicating it plays important roles in regulating the host immune response in physiological and pathological conditions [18]. In fungal infections like aspergillosis [43], candidiasis [24], cryptococcosis [22], paracoccidioidomicoses [23,25] and histoplasmosis [17] the influence of Gal-3 was analyzed through the main organs affected by these pathogens such as lungs, spleens and brains. In this study, we conducted expression profiling of genes involved in the host innate immune system in lungs, spleens and brains of Gal-3 KO mice. Our results showed that the absence of Gal-3 promotes both positive and negative modulation of genes encoding PRRs that bind beta-glucan, mannose and chitin, and genes involved in signal transduction, inflammation and phagocytosis. In the lungs and spleen, these genes were preferentially negatively modulated, while in the brain genes were predominantly positively modulated.

The importance of lectins during the innate immune response has been gaining prominence [44]. The antifungal immune response involves fungal recognition by pattern recognition receptors such as C-type lectin receptors (CLRs) [45,46] will mediate the host immune response through opsonization, complement system activation, phagocytosis, and inflammation [15,47]. Also, collectins, pentraxins and complement system proteins can facilitate the engulfment of pathogens by acting as opsonins, as well as promoting direct fungicidal effects [48].

The recognition of fungal pathogens by Gal-3 can be performed in conjunction with Dectin-1, PRR responsible for the recognition of beta glucan, in which macrophages expressing these two lectins are able to produce TNF-α in response to pathogens such as Saccharomyces cerevisiae and Candida albicans [49]. Moreover, Gal-3 can promote killing of C.albicans by binding to beta-1,2-linked oligomannans on the cell surface [50]. Our results suggest that Gal-3 KO promotes both reduced and enhanced expression of genes involved in pathogen recognition in the absence of apathogenic stimulus. This could have implications on the immune response following a fungal infection because Gal-3, as well as other members of the galectin family, they can act as PRRs capable of discriminating the glycans present in the pathogen and host, playing an important role in immune defense [51,52].

Gal-3 may also participate in the phagocytosis of microorganisms by macrophages, triggering activation of the immune system in vitro [53,54]. Corroborating our results that showed the decrease in the expression of genes involved in phagocytosis, Sano et al., have verified that Gal-3 KO macrophages showed delayed phagocytosis compared to WT [55]. The addition of exogenous Gal-3 can promote the activation of macrophages in a manner dependent on the properties of this lectin. The hypothesis for the role of Gal-3 in phagocytosis would be that Gal-3 binds to the pathogen and promotes the engulfment by macrophages [55]

C-type lectins such as the mannose-binding protein (Mbl2) and galectins may play a fundamental role in neutralizing the pathogen and conducting adaptive immunity [56]. Our results demonstrated that Mbl2, which can bind to different sugars, including GlcNAc, mannose, fucose and glucose [57], was overexpressed in lungs of Gal-3 KO compared to WT animals. The relationship between Gal-3 and Mbl2 is still unknown, but their interaction may promote several effector functions in the immune system [58].

Gal-3 deletion decreased the expression of chemokines and their receptors (ccl20, cxcl1, cxcl3, cxcl10, cxcl11, ccr5), as well as other molecules involved in inflammatory processes (c3, csf2, il-1α, il-1β, il-6, il-12) in the lungs and spleen. In agreement with our results, in vitro and in vivo studies suggest that Gal-3 is important for modulating inflammatory responses due to its roles in cell activation and migration or inhibition of apoptosis [6]. These observations are also supported by studies showing increased expression of galectins and chemokines in inflammatory conditions such as atherosclerosis and osteoarthritis [59–61]. Thus, our results reinforce that Gal-3 is a multifunctional protein involved in several biological events and may play crucial roles in gene expression during the host innate immune response.

Conclusion

Our results suggested that Gal-3 deletion has implications on the expression of genes involved in PRRs, signal transduction, inflammation and phagocytosis. We hypothesized that Gal-3 may also exert its effects by modulating host immunity. However, additional studies are required to better understand the mechanisms involved and identify whether Gal-3 is an attractive target for the development of therapeutic strategies to enhance antifungal immunity.

Supplementary Material

Supplemental Material

Acknowledgments

We thank Patricia Vendruscolo and Carlos Alberto Vieira for technical support.

Funding Statement

This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico [420670/2018-1]; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FAEPA); Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [2016/03322-7, 2016/25167-3].

Disclosure statement

The authors declare no conflict of interest.

Supplementary material

Supplemental data for this article can be accessed here

References

  • [1].Barondes SH, Castronovo V, Cooper DNW, etal. Galectins: afamily of animal beta-galactoside-binding lectins. Cell. 1994. February;76(4):597–598. ISSN 0092-8674. [DOI] [PubMed] [Google Scholar]
  • [2].Cooper DN. Galectinomics: finding themes in complexity. Biochim Biophys Acta. 2002. September;1572(2–3):209–231. ISSN 0006-3002. [DOI] [PubMed] [Google Scholar]
  • [3].Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer. 2005. January;5(1):29–41. ISSN 1474-175X. [DOI] [PubMed] [Google Scholar]
  • [4].Brewer CF, Miceli MC, Baum LG. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol. 2002. October;12(5):616–623. ISSN 0959-440X. [DOI] [PubMed] [Google Scholar]
  • [5].Fred Brewer C. Binding and cross-linking properties of galectins. Biochim Biophys Acta. 2002. September;1572(2–3):255–262. ISSN 0006-3002. [DOI] [PubMed] [Google Scholar]
  • [6].Rabinovich GA, Baum LG, Tinari N, etal. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 2002. June;23(6):313–320. ISSN 1471-4906. [DOI] [PubMed] [Google Scholar]
  • [7].Albrandt K, Orida NK, Liu FT. An IgE-binding protein with adistinctive repetitive sequence and homology with an IgG receptor. Proc Natl Acad Sci USA. 1987. October;84(19):6859–6863. ISSN 0027-8424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta. 2002. September 19;1572(2–3):263–273. ISSN 0006-3002. [DOI] [PubMed] [Google Scholar]
  • [9].Agrwal N, Wang JL, Voss PG. Carbohydrate-binding protein 35. Levels of transcription and mRNA accumulation in quiescent and proliferating cells. JBiol Chem. 1989;264(29):17236–17242. [PubMed] [Google Scholar]
  • [10].Moutsatsos IK, Davis JM, Wang JL. Endogenous lectins from cultured cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. JCell Biol. 1986;102(2):477–483. ISSN 0021-95251540-8140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Shimura T, Takenaka Y, Tsutsumi S, etal. Galectin-3, anovel binding partner of beta-catenin. Cancer Res. 2004. September;64(18):6363–6367. ISSN 0008-5472. [DOI] [PubMed] [Google Scholar]
  • [12].Dabelic S, Supraha S, Dumic J. Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs. Biochim Biophys Acta. 2006. April;1760(4):701–709. ISSN 0006-3002. [DOI] [PubMed] [Google Scholar]
  • [13].Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006. April;1760(4):616–635. ISSN 0006-3002. [DOI] [PubMed] [Google Scholar]
  • [14].Chung AW, Sieling PA, Schenk M, etal. Galectin-3 regulates the innate immune response of human monocytes. JInfect Dis. 2013;207(6):947–956. ISSN 1537-6613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Pelka K, Nardo DE. D.emerging concepts in innate immunity. Methods Mol Biol. 2018;1714: 1–18. ISSN 1064-3745. [DOI] [PubMed] [Google Scholar]
  • [16].Sehrawat S, Kaur M. Galectin-3 as amodifier of anti-microbial immunity: unraveling the unknowns. Glycobiology. 2020;30(7):418–426. ISSN 1460-2423. [DOI] [PubMed] [Google Scholar]
  • [17].Wu SY, Yu J-S, Liu F-T, etal. Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17–Axis cytokines in infection by Histoplasma capsulatum. JImmunol. 2013. April;190(7):3427–3437. ISSN 1550-6606. 10.4049/jimmunol.1202122 [DOI] [PubMed] [Google Scholar]
  • [18].Sciacchitano S, Lavra L, Morgante A, etal. Galectin-3: one molecule for an alphabet of diseases, from A to Z. IntJMol Sci. 2018. January 26;19(2):379. ISSN 1422-0067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Colnot C, Sidhu SS, Balmain N, etal. Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones. Dev Biol. 2001. January 1;229(1):203–214. ISSN 0012-1606. [DOI] [PubMed] [Google Scholar]
  • [20].Hsu DK, Yang R-Y, Pan Z, etal. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am JPathol. 2000. March;156(3):1073–1083. ISSN 0002-9440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Sartim AG, Sartim MA, Cummings RD, etal. Impaired emotional response to stress in mice lacking galectin-1 or galectin-3. Physiol Behav. 2020/06/01/2020. ISSN 0031-9384 2020;220:112862. [DOI] [PubMed] [Google Scholar]
  • [22].Almeida F, Wolf JM, Da Silva TA etal. Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects. Nat Commun 2017/12/062017. ISSN 2041-1723. 2017;8(1): 1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Hatanaka O, Rezende CP, Moreno P, etal. Galectin-3 inhibits paracoccidioides brasiliensis growth and impacts paracoccidioidomycosis through multiple mechanisms. mSphere. 2019. April 24;4(2). ISSN 2379-5042. doi: 10.1128/mSphere.00209-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Linden JR, De Paepe ME, Laforce-Nesbitt SS, etal. Galectin-3 plays an important role in protection against disseminated candidiasis. Med Mycol. 2013. August;51(6):641–651. ISSN 1460-2709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Ruas LP, Bernardes ES, Fermino ML, etal. Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS One. 2009;4(2):e4519. ISSN 1932-6203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med. 2008. June;10:e17. ISSN 1462-3994. [DOI] [PubMed] [Google Scholar]
  • [27].Mendonça Belmont TFD, Do Ó KP, Soares Da Silva A, etal. Single nucleotide polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) related to lower GAL-3 serum levels are associated with frequent respiratory tract infection and vaso-occlusive crisis in children with sickle cell anemia. PloS One. 2016;11(9):e0162297–e0162297. ISSN 1932-6203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Atabaki M, Hashemi M, Daneshvar H etal., Lectin, galactoside-binding, soluble, 3 rs4652 A/C gene variation and the risk for rheumatoid arthritis. Biomed Rep ISSN 2049-9434 2049-9442. 2017;6(2): 251–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Tian K, Wang L, Wang K, etal. Analysis of variants at LGALS3 single nucleotide polymorphism loci in skull base chordoma. Oncol Lett. 2018. July;16(1):1312–1320. ISSN 1792-1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Zhang Y, Wang Y, Zhai M, etal. Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in aNorthern Han Chinese population. Gene. 2018. February 5 ISSN 0378-1119;642:293–298. [DOI] [PubMed] [Google Scholar]
  • [31].Tang T, Dai Y, Zeng Q, etal. Pentraxin-3 polymorphisms and pulmonary fungal disease in non-neutropenic patients. Ann Transl Med. 2020;8(18):1142. ISSN 2305-58392305-5847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Zhou P, Xie Y, Yan Z, etal. Association between dectin-1 gene single nucleotide polymorphisms and fungal infection: asystemic review and meta-analysis. Biosci Rep. 2019;39(11):BSR20191519. ISSN 1573-49350144-8463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Grube M, Loeffler J, Mezger M, etal. TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation. Med Mycol. 2013. November;51(8):818–825. ISSN 1369-3786. [DOI] [PubMed] [Google Scholar]
  • [34].Cunha C, Di Ianni M, Bozza S, etal. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood. 2010. December 9;116(24):5394–5402. ISSN 0006-4971. [DOI] [PubMed] [Google Scholar]
  • [35].Sainz J, Lupiáñez CB, Segura-Catena J, etal. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection. PLoS One. 2012;7(2):e32273. ISSN 1932-6203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Cunha C, Aversa F, Lacerda JF, etal. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. NEngl JMed. 2014. January 30;370(5):421–432. ISSN 0028-4793. [DOI] [PubMed] [Google Scholar]
  • [37].Sainz J, Pérez E, Hassan L, etal. Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum Immunol. 2007. January;68(1):41–50. ISSN 0198-8859. [DOI] [PubMed] [Google Scholar]
  • [38].Sainz J, Salas-Alvarado I, López-Fernández E, etal. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. IntJImmunopathol Pharmacol. 2010. Apr-Jun;23(2):423–436. ISSN 0394-6320. [DOI] [PubMed] [Google Scholar]
  • [39].Lupiañez CB, Villaescusa MT, Carvalho A, etal. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis. Front Microbiol. ISSN 1664-302X 2016;7: 1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Nakahara S, Oka N, Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis. 2005/03/01 2005. ISSN 1573-675X. 2005;10(2):267–275. [DOI] [PubMed] [Google Scholar]
  • [41].Chaudhari AD, Gude RP, Kalraiya RD, etal. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice. Mol Immunol. 2015. December;68(2 Pt A):300–311. ISSN 0161-5890. [DOI] [PubMed] [Google Scholar]
  • [42].Kouo T, Huang L, Pucsek AB, etal. Galectin-3 shapes antitumor immune responses by suppressing CD8+ Tcells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells. Cancer Immunol Res. 2015;3(4):412–423. ISSN 2326-60742326-6066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Snarr BD, St-Pierre G, Ralph B, etal. Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection. PLoS Pathog. 2020;16(8):e1008741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Garred P, Genster N, Pilely K etal., Ajourney through the lectin pathway of complement—MBL and beyond. Immunol Rev 2016/11/01 2016. ISSN 0105-2896. 2016;274(1): 74–97. [DOI] [PubMed] [Google Scholar]
  • [45].Salazar F, Brown GD. Antifungal innate immunity: aperspective from the last 10 years. JInnate Immun. 2018;10(5–6):373–397. ISSN 1662-81281662-811X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Speakman EA, Dambuza IM, Salazar F, etal. Tcell antifungal immunity and the role of C-type lectin receptors. Trends Immunol. 2020;41(1):61–76. ISSN 1471-49811471-4906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Heung LJ. Innate immune responses to cryptococcus. JFungi (Basel). 2017;3(3): 35. ISSN 2309-608X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Ma YJ, Lee BL, Garred P. An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. Exp Mol Med. 2017;49(4):e320–e320. ISSN 2092-64131226-3613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Esteban A, Popp MW, Vyas VK, etal. Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages. Proc Natl Acad Sci USA. 2011;108(34):14270–14275. ISSN 1091-64900027-8424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Kohatsu L, Hsu DK, Jegalian AG, etal. Galectin-3 induces death of candida species expressing specific β-1,2-Linked mannans. JImmunol. 2006. October 1;177(7):4718–4726. ISSN 0022-1767. [DOI] [PubMed] [Google Scholar]
  • [51].Baum LG, Garner OB, Schaefer K, etal. Microbe–host interactions are positively and negatively regulated by Galectin–Glycan interactions. Front Immunol. ISSN 1664-3224 2014;5: 284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Díaz-alvarez L, Ortega E. The many roles of Galectin-3, amultifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm. 2017;2017:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Liu FT, Hsu DK, Zuberi RI, etal. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am JPathol. 1995;147(4):1016–1028. ISSN 0002-94401525-2191. [PMC free article] [PubMed] [Google Scholar]
  • [54].Sano H, Hsu DK, Yu L, etal. Human Galectin-3 is anovel chemoattractant for monocytes and macrophages. JImmunol. 2000;165(4):2156. [DOI] [PubMed] [Google Scholar]
  • [55].Sano H, Hsu DK, Apgar JR, etal. Critical role of galectin-3 in phagocytosis by macrophages. JClin Invest. 2003;112(3):389–397. ISSN 0021-9738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Vasta GR, Quesenberry M, Ahmed H etal., C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway. Dev Comp Immunol 1999/06/01/1999. ISSN 0145-305X. 1999;23(4): 401–420. [DOI] [PubMed] [Google Scholar]
  • [57].Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003/11/01/2003. ISSN 0161-5890. 2003;40(7):423–429. [DOI] [PubMed] [Google Scholar]
  • [58].Ma YJ, Doni A, Romani L, etal. Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production. JImmunol. 2013. August 1;191(3):1324–1333. ISSN 0022-1767. [DOI] [PubMed] [Google Scholar]
  • [59].Filer A, Bik M, Parsonage GN, etal. Galectin 3 induces adistinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheumatism. 2009;60(6):1604–1614. ISSN 0004-35911529-0131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Nachtigal M, Ghaffar A, Mayer EP. Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am JPathol. 2008;172(1):247–255. ISSN 0002-94401525-2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Wu S-Y, Yu J-S, Liu F-T, etal. Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17–Axis cytokines in infection by Histoplasma capsulatum. Journal of immunology (Baltimore, Md.: 1950). 190(7)03January 2013; doi: 10.4049/jimmunol.1202122. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Articles from Virulence are provided here courtesy of Taylor & Francis

RESOURCES